Skip to content
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
PONIF$0.12-0.00(-3.70%)Silver Pony Announces Closing of Up-Sized $1,600,015 Strategic Unit Offering[6:15:00 PM ET]ELME$0.07-1.70(-96.19%)Elme Communities Announces Suspended NYSE Trading; Anticipates Trading Will Begin OTC Effective October 26, 2026[5:47:00 PM ET]HHH$72.57+3.08(+4.43%)Howard Hughes Holdings Set to Join S&P SmallCap 600 Howard Hughes Holdings Inc. (NYSE: HHH) will replace Arcosa Inc. (NYSE: ACA) in the S&P SmallCap 600 effective prior to the opening of trading on...[5:45:00 PM ET]ALGRF$0.400.00(0.00%)Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita[5:30:00 PM ET]ZEFIF$0.45+0.02(+3.56%)Zefiro Announces Closing of Non-Brokered Private Placement for Gross Proceeds of Approximately C$5.0 Million[5:29:00 PM ET]BLK$1,118.50-18.79(-1.65%)BlackRock® Canada Announces the Termination of iShares Convertible Bond Index ETF[5:23:34 PM ET]ITFS$1.43-0.02(-1.10%)Itafos Announces Release Date for Q3 2026 Results and Business Update Webcast[5:15:00 PM ET]FAGI$0.01-0.00(-13.33%)Full Alliance Group, Inc (OTC:FAGI) YAHBEE Highlights Community-Commerce Model for Agentic Commerce Era[5:15:00 PM ET]TGT$152.76-5.35(-3.38%)Vital Farms Introduces a Higher Standard for Free-Range Eggs Through Limited Pilot at Select Target Retail Stores[5:05:00 PM ET]NU$15.23+0.50(+3.39%)Notice to Market: Nu Holdings Ltd.[5:03:00 PM ET]POR$44.55-0.35(-0.78%)Portland General Electric Declares Dividend[5:00:00 PM ET]ANTX$3.55-0.09(-2.47%)AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(c)(4)[5:00:00 PM ET]

IQV · NYSE

IQVIA Holdings Inc.

$279.36 +1.13 (+0.41%)

Company overview

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers cloud-based applications, real-world evidence solutions, and strategic consulting services. The Research & Development Solutions segment provides project management, clinical monitoring, clinical trial support, virtual trials, and laboratory services including central laboratory, genomic, bioanalytical, and biomarker services. The Contract Sales & Medical Solutions segment offers healthcare provider and patient engagement services and medical affairs support.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NYSE
Market cap
$46B
Employees
89,000
Headquarters
Durham, NC
Website
iqvia.com
CEO
Ari Bousbib
Listed
May 9, 2013
P/E
34.32
Dividend yield
0.00%

Company financials

Revenue
$16.6B
Gross profit
$4.3B
Operating income
$2.3B
EBITDA
$3.5B
Net income
$1.4B
EPS
$8.14
Total assets
$29.7B
Total debt
$2.1B
Gross margin
26.11%
Net margin
8.33%
Earnings yield
2.91%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

149.36184.05218.74253.43288.12
IQV 1D NYSE O274.99H282.98L273.80C278.32+1.69 (+0.61%)Vol1.67M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
Ticker Type Headline Source Published
IQV Stock news IQVIA Gears Up to Post Q3 Earnings: Here's What Investors Should Know Zacks Investment Research
IQV Press release The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape GlobeNewswire
IQV Stock news IQVIA opte pour les applications de Veeva Clinical Operations PRNewsWire
IQV Stock news Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock Zacks Investment Research
IQV Stock news Extensive Database & Solid Bookings Benefit IQVIA Amid Low Liquidity Zacks Investment Research
IQV Stock news Contrasting IQVIA (NYSE:IQV) and Bullfrog AI (NASDAQ:BFRG) Defense World
IQV Stock news IQVIA Stock Rises 60% in 6 Months: Here's What You Should Know Zacks Investment Research
IQV Press release Life Science Analytics Market Poised for Strong Growth GlobeNewswire
IQV Stock news Why IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-Term Zacks Investment Research
IQV Stock news Arizona State Retirement System Buys 2,372 Shares of IQVIA Holdings Inc. $IQV Defense World
IQV Stock news B. Metzler seel. Sohn & Co. AG Lowers Holdings in IQVIA Holdings Inc. $IQV Defense World
IQV Stock news Why Is IQVIA (IQV) Up 5.6% Since Last Earnings Report? Zacks Investment Research
IQV Stock news Here's Why You Should Retain IQVIA Stock in Your Portfolio Now Zacks Investment Research
IQV Stock news BlackRock Inc. Takes Position in IQVIA Holdings Inc. $IQV Defense World
IQV Stock news IQV Stock Gains 42% in 3 Months: Here's What You Should Know Zacks Investment Research
IQV Stock news Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term Zacks Investment Research
IQV Stock news IQVIA Holdings (IQV) is a Top-Ranked Momentum Stock: Should You Buy? Zacks Investment Research
IQV Stock news Is IQVIA Stock a Buy as Growth Improves but High Leverage Persists? Zacks Investment Research
IQV Stock news Why IQVIA Stock Jumped 13% in a Week and Whether the Gains Can Last Zacks Investment Research
IQV Stock news IQVIA Holdings Inc. $IQV Shares Sold by Dai ichi Life Insurance Company Ltd Defense World
FAQ

Questions about IQVIA Holdings Inc.

What does IQVIA Holdings Inc. do?
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers cloud-based applications, real-world evidence solutions, and strategic consulting services. The Research & Development Solutions segment provides project management, clinical monitoring, clinical trial support, virtual trials, and laboratory services including central laboratory, genomic, bioanalytical, and biomarker services. The Contract Sales & Medical Solutions segment offers healthcare provider and patient engagement services and medical affairs support.
What is IQV's market cap?
IQVIA Holdings Inc. (IQV) is a listed stock with a live quote. The latest market cap on this page is $46B.
Where is IQVIA Holdings Inc. headquartered?
IQVIA Holdings Inc. is headquartered in Durham, NC.
How do I get IQV news from the API?
Call GET /v1/news?tickers=IQV. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does IQV news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for IQV, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the IQV price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included. If you don't subscribe, the account stays on Free.